Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	1318	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	1993	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	3143	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y